Similar articles

• Antiperinuclear factor in an Italian series of patients with rheumatoid arthritis.

  Cassani F, Ferri S, Bianchi FB, Marsili R, Zauli D, Pisi E. Cassani F, et al. Ric Clin Lab. 1983 Jul-Sep;13(3):347-52. doi: 10.1007/BF02905878. Ric Clin Lab. 1983. PMID: 6606208
• [Antiperinuclear factors in psoriasis. Correlation with other serological abnormalities in 90 patients].

  Youinou P, Massé R, Peu-Duvallon P, Le Roux P, Grulier A, Miossec P, Dorval JC, Lizan G, Férec C, Le Goff P. Youinou P, et al. Ann Dermatol Venereol. 1982;109(4):359-64. Ann Dermatol Venereol. 1982. PMID: 6751193 French.
• Interlaboratory variability of the antiperinuclear factor (APF) test for rheumatoid arthritis.

  Feltkamp TE, Berthelot JM, Boerbooms AM, Geertzen HG, Hoet R, De Keyser F, van Venrooij WJ, Verbruggen G, Veys EM, Youinou P. Feltkamp TE, et al. Clin Exp Rheumatol. 1993 Jan-Feb;11(1):57-9. Clin Exp Rheumatol. 1993. PMID: 8453800
• The antiperinuclear factor. I. Clinical and serologic associations.

  Youinou P, Le Goff P, Dumay A, Lelong A, Fauquert P, Jouquan J. Youinou P, et al. Clin Exp Rheumatol. 1990 May-Jun;8(3):259-64. Clin Exp Rheumatol. 1990. PMID: 1696191 Review.
• The antiperinuclear factor and antikeratin antibody systems.

  Youinou P, Serre G. Youinou P, et al. Int Arch Allergy Immunol. 1995 Aug;107(4):508-18. doi: 10.1159/000237093. Int Arch Allergy Immunol. 1995. PMID: 7542514 Review.